University Library
  • Login
A gateway to Melbourne's research publications
Minerva Access is the University's Institutional Repository. It aims to collect, preserve, and showcase the intellectual output of staff and students of the University of Melbourne for a global audience.
View Item 
  • Minerva Access
  • Engineering and Information Technology
  • Chemical and Biomolecular Engineering
  • Chemical and Biomolecular Engineering - Research Publications
  • View Item
  • Minerva Access
  • Engineering and Information Technology
  • Chemical and Biomolecular Engineering
  • Chemical and Biomolecular Engineering - Research Publications
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

    RNAi therapeutics: an antiviral strategy for human infections

    Thumbnail
    Download
    Published version (1.056Mb)

    Citations
    Altmetric
    Author
    Kelleher, AD; Cortez-Jugo, C; Cavalieri, F; Qu, Y; Glanville, AR; Caruso, F; Symonds, G; Ahlenstiel, CL
    Date
    2020-10
    Source Title
    Current Opinion in Pharmacology
    Publisher
    Elsevier BV
    University of Melbourne Author/s
    Caruso, Francesco; Cortez-Jugo, Christina; Cavalieri, Francesca; Qu, Yijiao
    Affiliation
    Chemical and Biomolecular Engineering
    Metadata
    Show full item record
    Document Type
    Journal Article
    Citations
    Kelleher, A. D., Cortez-Jugo, C., Cavalieri, F., Qu, Y., Glanville, A. R., Caruso, F., Symonds, G. & Ahlenstiel, C. L. (2020). RNAi therapeutics: an antiviral strategy for human infections. Current Opinion in Pharmacology, 54, pp.121-129. https://doi.org/10.1016/j.coph.2020.09.011.
    Access Status
    Open Access
    URI
    http://hdl.handle.net/11343/251833
    DOI
    10.1016/j.coph.2020.09.011
    Open Access URL
    https://doi.org/10.1016/j.coph.2020.09.011
    Abstract
    Gene silencing induced by RNAi represents a promising antiviral development strategy. This review will summarise the current state of RNAi therapeutics for treating acute and chronic human virus infections. The gene silencing pathways exploited by RNAi therapeutics will be described and include both classic RNAi, inducing cytoplasmic mRNA degradation post-transcription and novel RNAi, mediating epigenetic modifications at the transcription level in the nucleus. Finally, the challenge of delivering gene modifications via RNAi will be discussed, along with the unique characteristics of respiratory versus systemic administration routes to highlight recent advances and future potential of RNAi antiviral treatment strategies.

    Export Reference in RIS Format     

    Endnote

    • Click on "Export Reference in RIS Format" and choose "open with... Endnote".

    Refworks

    • Click on "Export Reference in RIS Format". Login to Refworks, go to References => Import References


    Collections
    • Minerva Elements Records [52369]
    • Chemical and Biomolecular Engineering - Research Publications [649]
    Minerva AccessDepositing Your Work (for University of Melbourne Staff and Students)NewsFAQs

    BrowseCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
    My AccountLoginRegister
    StatisticsMost Popular ItemsStatistics by CountryMost Popular Authors